John T Larinto PA

Recommended Articles

• What is an Open Cholecystectomy?

  Open cholecystectomy, also known as open gall bladder removal, is a surgical procedure which involves removal of the gallbladder through creation of a large opening in the abdomen. The main aim of this surgical operation is to provide relief to people suffering from gallstones and other...

• The Many Benefits of Cayenne Pepper

  What is cayenne pepper?Cayenne pepper, more commonly known as red hot chili pepper, is used to spice our dishes and add more taste to the food we eat. Some of other names that are used to refer to it include Guinea spice, cow horn pepper, aleva and bird pepper. The word Cayenne comes from the city...

• Risky Surgery Gives Man with Rheumatoid Arthritis Ability to Look Up After Decades

  When Rodney Wente started experiencing pain and discomfort in his lower back, he knew that it couldn’t be good news. He was already dealing with rheumatoid arthritis, an autoimmune condition that caused inflammation all over his body. He was getting older, and his body was beginning to fail. When...

• What Causes a Cough?

  Although a cough is a very common condition, it is not considered a disease. It is usually the symptom of an underlying condition or is a reflex action to remove irritants and mucus from the respiratory tract. In most cases, a cough clears within a week or so. Although a cough may not be very...

• Dementia and Related Psychosis: Should Antipsychotic Drugs Really Be Used?

  Alzheimer’s is one of the primary causes of age-related dementia, and it's typically characterized by the progressive loss of connectivity between brain cells and their death, leading not only to the loss of memory and cognition, but also difficulties in social interaction.As the disease...

• FDA Approves Baricitinib for Adults with Active Rheumatoid Arthritis

  On June 1st of 2018, the US Food and Drug Administration (FDA) approved Olumiant (Baricitinib) for the treatment of adults with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more TNF inhibitor therapies. “We are pleased to provide RA...